APA (7th ed.) Citation

L, O., C, R., TL, S., DE, W., M, C., L, T., . . . BJ, G. (2011). A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents. Diabetes, obesity & metabolism, 13(9), 841. https://doi.org/10.1111/j.1463-1326.2011.01416.x

Chicago Style (17th ed.) Citation

L, Olansky, Reasner C, Seck TL, Williams-Herman DE, Chen M, Terranella L, Mehta A, Kaufman KD, and Goldstein BJ. "A Treatment Strategy Implementing Combination Therapy with Sitagliptin and Metformin Results in Superior Glycaemic Control Versus Metformin Monotherapy Due to a Low Rate of Addition of Antihyperglycaemic Agents." Diabetes, Obesity & Metabolism 13, no. 9 (2011): 841. https://doi.org/10.1111/j.1463-1326.2011.01416.x.

MLA (9th ed.) Citation

L, Olansky, et al. "A Treatment Strategy Implementing Combination Therapy with Sitagliptin and Metformin Results in Superior Glycaemic Control Versus Metformin Monotherapy Due to a Low Rate of Addition of Antihyperglycaemic Agents." Diabetes, Obesity & Metabolism, vol. 13, no. 9, 2011, p. 841, https://doi.org/10.1111/j.1463-1326.2011.01416.x.